A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors

Local Institution - 0028, Clayton

Local Institution - 0050, Brussels

Local Institution - 0051, Edegem

Local Institution - 0049, Leuven

Local Institution - 0017, New York

Local Institution - 0024, Rochester

Local Institution - 0037, Allentown

Local Institution - 0014, Philadelphia

Local Institution - 0020, Philadelphia

Local Institution - 0018, Washington D.C.

Local Institution - 0005, Baltimore

Local Institution - 0042, Charlottesville

Local Institution - 0032, Madrid

Local Institution - 0046, Charlotte

Local Institution - 0030, Majadahonda - Madrid

Local Institution - 0045, Charleston

Local Institution - 0047, St. Petersburg

Local Institution - 0048, Brooksville

Local Institution - 0003, Birmingham

Local Institution - 0034, Nashville

Local Institution - 0038, Nashville

Local Institution - 0039, Hattiesburg

Local Institution - 0021, Cleveland

Local Institution - 0023, St Louis

Local Institution - 0007, Heidelberg

Local Institution - 0015, Aurora

Local Institution - 0016, Salt Lake City

Local Institution - 0026, Phoenix

Local Institution - 0002, Los Angeles

Local Institution - 0025, Los Angeles

Local Institution - 0041, Orange

Local Institution - 0033, Boston

Local Institution - 0027, Rochester

Local Institution - 0004, Hackensack

Local Institution - 0044, Cleveland

Local Institution - 0013, Edmonton

Local Institution - 0012, Ottawa

Local Institution - 0001, Toronto

Local Institution - 0022, Dresden

Local Institution - 0031, Barcelona